Boston Scientific - BSX Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $60.10
Forecasted Upside: 12.12%
Number of Analysts: 17
Breakdown:
0 Sell Ratings
1 Hold Ratings
15 Buy Ratings
1 Strong Buy Ratings

^$53.60 As of 09/22/2023 01:00 AM ET

▼ -0.37 (-0.69%)

1 month | 3 months | 12 months

Get New Boston Scientific Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for BSX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSX

^$60.10

▲ +12.12% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.10, with a high forecast of $66.00 and a low forecast of $50.00. The average price target represents a 12.12% upside from the last price of $53.60.

Current Consensus is Buy

The current consensus among 17 investment analysts is to buy stock in Boston Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/1/2022

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/30/2022

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/28/2022

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/27/2022

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/27/2023

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/25/2023

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

8/24/2023

1 strong buy ratings
15 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/23/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
9/22/2023	Barclays	Boost Target	Overweight ➝ Overweight	$59.00 ➝ $60.00	Low
9/21/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$61.00	Low
9/21/2023	Canaccord Genuity Group	Boost Target	Buy ➝ Buy	$62.00 ➝ $64.00	Low
9/21/2023	Citigroup	Reiterated Rating	Buy ➝ Buy	$63.00	Low
9/21/2023	BTIG Research	Boost Target	Buy ➝ Buy	$62.00 ➝ $64.00	Low
9/21/2023	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$58.00 ➝ $61.00	Low
9/21/2023	UBS Group	Boost Target	Buy ➝ Buy	$63.00 ➝ $66.00	Low
9/21/2023	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$58.00 ➝ $60.00	Low
9/21/2023	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$60.00 ➝ $63.00	Low
9/21/2023	Mizuho	Boost Target	Neutral ➝ Neutral	$56.00 ➝ $60.00	Low
9/20/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$61.00	Low
9/19/2023	Evercore ISI	Reiterated Rating	Outperform ➝ Outperform	$60.00	Low
9/11/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$61.00	Low
8/28/2023	Citigroup	Reiterated Rating	Buy ➝ Buy	$63.00	Low
8/28/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$61.00	Low
8/28/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$58.00	Low
8/28/2023	Mizuho	Reiterated Rating	Neutral ➝ Neutral	$56.00	Low
8/11/2023	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$61.00	Low
7/31/2023	Barclays	Boost Target	Overweight ➝ Overweight	$56.00 ➝ $59.00	Low
7/28/2023	Canaccord Genuity Group	Boost Target	Buy	$58.00 ➝ $62.00	Low
7/28/2023	Raymond James	Boost Target		$60.00 ➝ $61.00	Low
7/28/2023	Needham & Company LLC	Boost Target	Buy	$57.00 ➝ $61.00	Low
7/28/2023	Oppenheimer	Boost Target		$58.00 ➝ $59.00	Low
7/19/2023	Truist Financial	Boost Target		$60.00 ➝ $61.00	Low
7/18/2023	Robert W. Baird	Initiated Coverage	Outperform	$59.00	Low
7/17/2023	BTIG Research	Boost Target		$56.00 ➝ $57.00	Low
7/12/2023	Royal Bank of Canada	Boost Target		$56.00 ➝ $58.00	Low
7/6/2023	Piper Sandler	Boost Target		$58.00 ➝ $62.00	Low
6/30/2023	22nd Century Group	Reiterated Rating	Initiates		Low
6/30/2023	CL King	Initiated Coverage	Buy	$64.00	Low
5/30/2023	Morgan Stanley	Initiated Coverage	Overweight	$58.00	Low
4/27/2023	Stifel Nicolaus	Boost Target		$52.00 ➝ $58.00	Low
4/27/2023	Royal Bank of Canada	Boost Target		$53.00 ➝ $56.00	Low
4/27/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$45.00 ➝ $55.00	Low
4/27/2023	Barclays	Boost Target		$53.00 ➝ $56.00	Low
4/18/2023	Mizuho	Boost Target		$52.00 ➝ $56.00	Low
4/17/2023	Truist Financial	Boost Target	Buy	$54.00 ➝ $59.00	Low
4/17/2023	BTIG Research	Boost Target	Buy	$53.00 ➝ $54.00	Low
4/17/2023	Raymond James	Boost Target	Strong-Buy	$56.00 ➝ $60.00	Low
4/3/2023	Citigroup	Boost Target	Buy	$54.00 ➝ $60.00	Low
3/28/2023	UBS Group	Initiated Coverage	Buy	$57.00	Low
2/17/2023	Argus	Boost Target		$50.00 ➝ $55.00	Low
2/2/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$48.00 ➝ $55.00	Low
2/2/2023	Needham & Company LLC	Boost Target	Buy	$48.00 ➝ $53.00	Low
2/2/2023	Raymond James	Boost Target	Strong-Buy	$54.00 ➝ $56.00	Low
2/1/2023	Stifel Nicolaus	Boost Target		$50.00 ➝ $52.00	Low
1/6/2023	Morgan Stanley	Boost Target	Overweight	$50.00 ➝ $56.00	Low
1/4/2023	Barclays	Boost Target		$49.00 ➝ $53.00	Low
12/22/2022	Mizuho	Initiated Coverage	Neutral	$52.00	Low
12/20/2022	Truist Financial	Boost Target	Buy	$50.00 ➝ $54.00	Low
12/20/2022	Citigroup	Initiated Coverage	Buy	$54.00	Low
12/8/2022	Raymond James	Boost Target		$48.00 ➝ $54.00	Low
10/28/2022	Canaccord Genuity Group	Boost Target	Buy ➝ Buy	$45.00 ➝ $48.00	Low
10/17/2022	Barclays	Initiated Coverage	Overweight	$49.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Buy	$50.00	Low
10/11/2022	Morgan Stanley	Boost Target	Overweight	$49.00 ➝ $50.00	Low
9/9/2022	Piper Sandler	Boost Target	Overweight	$47.00 ➝ $50.00	Low
7/28/2022	Canaccord Genuity Group	Boost Target		$43.00 ➝ $45.00	Low
7/28/2022	BTIG Research	Boost Target	Buy	$45.00 ➝ $50.00	Low
7/20/2022	Truist Financial	Lower Target	Buy	$51.00 ➝ $45.00	Low
7/15/2022	Morgan Stanley	Lower Target	Overweight	$51.00 ➝ $46.00	Low
7/5/2022	Wolfe Research	Initiated Coverage	Outperform	$43.00	N/A
6/29/2022	Canaccord Genuity Group	Lower Target	Buy ➝ Buy	$51.00 ➝ $43.00	Low
6/24/2022	BTIG Research	Lower Target	Buy	$52.00 ➝ $45.00	Low
5/27/2022	Needham & Company LLC	Upgrade	Hold ➝ Buy	$48.00	Low
5/24/2022	BTIG Research	Reiterated Rating	Buy	$52.00	Low
5/17/2022	Citigroup	Lower Target	Buy	$52.00 ➝ $47.00	N/A
4/13/2022	Truist Financial	Initiated Coverage	Buy	$52.00	Low
3/1/2022	Bank of America	Initiated Coverage	Buy ➝ Buy		Medium
2/3/2022	Morgan Stanley	Lower Target	Overweight	$53.00 ➝ $51.00	Low
2/3/2022	Raymond James	Lower Target	Strong-Buy	$51.00 ➝ $49.00	High
2/3/2022	SVB Leerink	Lower Target	Market Perform	$48.00 ➝ $45.00	High
12/21/2021	Truist Financial	Boost Target	Buy	$52.00 ➝ $53.00	High
12/9/2021	Royal Bank of Canada	Initiated Coverage	Outperform	$51.00	Low
10/28/2021	Raymond James	Lower Target	Strong-Buy	$53.00 ➝ $51.00	Medium
9/21/2021	Morgan Stanley	Reiterated Rating	Buy	$53.00	Medium
7/28/2021	Credit Suisse Group	Boost Target	Outperform	$50.00 ➝ $52.00	Low
7/28/2021	Raymond James	Boost Target	Strong-Buy	$50.00 ➝ $53.00	Low
7/28/2021	Morgan Stanley	Boost Target	Overweight	$51.00 ➝ $53.00	Low
7/15/2021	Needham & Company LLC	Set Target	Hold	$42.74	Medium
6/7/2021	Argus	Boost Target	Buy	$45.00 ➝ $50.00	Low
5/26/2021	Needham & Company LLC	Downgrade	Buy ➝ Hold		High
5/24/2021	Barclays	Initiated Coverage	Overweight	$51.00	Low
4/29/2021	Truist Financial	Boost Target		$42.00 ➝ $50.00	Low
4/29/2021	Morgan Stanley	Boost Target	Overweight	$43.00 ➝ $51.00	Low
4/29/2021	Wells Fargo & Company	Boost Target	In-Line ➝ Overweight	$42.00 ➝ $50.00	Low
4/29/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$39.00 ➝ $45.00	Low
4/15/2021	Atlantic Securities	Initiated Coverage	Overweight	$52.00	High
2/12/2021	Needham & Company LLC	Boost Target	Buy	$43.00 ➝ $46.00	Low
2/4/2021	Raymond James	Boost Target	Strong-Buy	$39.00 ➝ $43.00	Low
2/3/2021	Piper Sandler	Boost Target	In-Line ➝ Overweight	$46.00 ➝ $48.00	High
2/1/2021	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold		Low
12/15/2020	Morgan Stanley	Boost Target	Overweight	$40.00 ➝ $43.00	Low
12/15/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium
12/8/2020	BTIG Research	Reiterated Rating	Buy		Low
11/18/2020	Truist Financial	Lower Target		$47.00 ➝ $44.00	Medium
11/18/2020	Smith Barney Citigroup	Lower Target		$46.00 ➝ $43.00	High
11/18/2020	Wells Fargo & Company	Lower Target	Overweight	$44.00 ➝ $41.00	High
11/18/2020	Morgan Stanley	Lower Target	Overweight	$41.00 ➝ $40.00	High
11/17/2020	Needham & Company LLC	Lower Target	Buy	$50.00 ➝ $43.00	High
10/29/2020	Morgan Stanley	Lower Target	Overweight	$48.00 ➝ $41.00	High
9/17/2020	Truist Financial	Initiated Coverage	Buy	$47.00 ➝ $47.00	High
9/11/2020	Wolfe Research	Initiated Coverage	Market Perform	$46.00	Medium
7/30/2020	Stifel Nicolaus	Boost Target	Buy	$45.00 ➝ $47.00	Low
7/30/2020	Jefferies Financial Group	Boost Target	Buy	$43.00 ➝ $46.00	Low
7/30/2020	Citigroup	Boost Target	Buy	$44.00 ➝ $46.00	Medium
7/30/2020	SVB Leerink	Boost Target	Market Perform	$40.00 ➝ $43.00	Medium
7/30/2020	Morgan Stanley	Boost Target	Overweight	$45.00 ➝ $48.00	Medium
7/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$50.00	Medium
7/29/2020	Oppenheimer	Boost Target	Market Perform	$41.00 ➝ $43.00	Medium
6/24/2020	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	Low
5/13/2020	Argus	Boost Target	Buy	$40.00 ➝ $42.00	Low
4/30/2020	CSFB	Boost Target	Outperform	$42.00 ➝ $43.00	High
4/30/2020	Wells Fargo & Company	Boost Target	Overweight	$40.00 ➝ $41.00	Low
4/30/2020	Credit Suisse Group	Boost Target	Outperform	$42.00 ➝ $43.00	Low
4/30/2020	Citigroup	Boost Target	Buy	$40.00 ➝ $42.00	Medium
4/30/2020	UBS Group	Lower Target	Buy	$50.00 ➝ $45.00	Medium
4/30/2020	Stifel Nicolaus	Boost Target	Buy	$35.00 ➝ $45.00	Medium
4/30/2020	Raymond James	Boost Target	Strong-Buy	$42.00 ➝ $43.00	High
4/30/2020	Oppenheimer	Reiterated Rating	Hold	$46.00 ➝ $41.00	Low
4/29/2020	BTIG Research	Reiterated Rating	Buy	$44.00	Low
4/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$46.00	Low
4/23/2020	SunTrust Banks	Lower Target	Buy	$28.00 ➝ $25.00	Low
4/22/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$40.00	Low
4/9/2020	Raymond James	Lower Target	Strong-Buy	$49.00 ➝ $42.00	High
4/2/2020	Piper Sandler	Reiterated Rating	Buy		Low
4/2/2020	Needham & Company LLC	Lower Target	Buy	$53.00 ➝ $43.00	Medium
4/1/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Conviction-Buy	$46.00 ➝ $38.00	High
3/27/2020	Citigroup	Lower Target	Buy	$48.00 ➝ $40.00	Low
3/24/2020	Stifel Nicolaus	Lower Target	Buy	$47.00 ➝ $30.00	High
3/23/2020	Stephens	Lower Target	Overweight	$48.00 ➝ $35.00	High
3/9/2020	Cfra	Upgrade	Buy ➝ Strong-Buy	$50.00 ➝ $47.00	Low
3/6/2020	Credit Suisse Group	Lower Target	Outperform	$51.00 ➝ $46.00	High
3/4/2020	Citigroup	Initiated Coverage	Buy	$48.00	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$46.00	Low
2/6/2020	BTIG Research	Initiated Coverage	Buy	$46.00	Low
1/15/2020	Cowen	Reiterated Rating	Buy	$52.00	Medium
1/14/2020	Piper Sandler	Reiterated Rating	Buy		Low
12/30/2019	Cowen	Boost Target	Outperform	$47.00 ➝ $52.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$50.00 ➝ $55.00	Low
12/19/2019	Needham & Company LLC	Downgrade	Strong-Buy ➝ Buy	$53.00	Low
12/17/2019	Morgan Stanley	Boost Target	Overweight	$50.00 ➝ $51.00	Medium
12/16/2019	Wells Fargo & Company	Boost Target	Overweight	$48.00 ➝ $52.00	Low
10/25/2019	Guggenheim	Set Target	Buy	$53.00	N/A
10/23/2019	Needham & Company LLC	Reiterated Rating	Buy	$53.00	Medium
10/14/2019	Raymond James	Lower Target	Strong-Buy	$50.00 ➝ $48.00	Low
9/30/2019	Stephens	Set Target	Buy	$48.00	Low
9/6/2019	Stifel Nicolaus	Set Target	Buy	$47.00	High
9/5/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight		Medium
9/3/2019	Barclays	Reiterated Rating	Overweight	$48.00	High
8/30/2019	Stifel Nicolaus	Set Target	Buy	$46.00	Low
8/29/2019	Morgan Stanley	Set Target	Buy	$50.00	Low
7/31/2019	SVB Leerink	Set Target	Buy	$50.00	Low
7/25/2019	Raymond James	Boost Target	Strong-Buy	$48.00 ➝ $50.00	Medium
7/24/2019	Needham & Company LLC	Set Target	Buy	$46.00	Low
7/24/2019	BTIG Research	Set Target	Buy	$46.00	Low
7/24/2019	Piper Jaffray Companies	Set Target	Buy	$50.00	Low
6/27/2019	Stifel Nicolaus	Boost Target	Buy ➝ In-Line	$44.00 ➝ $46.00	Medium
6/27/2019	Jefferies Financial Group	Boost Target	Buy ➝ Positive	$44.00 ➝ $48.00	Medium
6/27/2019	Piper Jaffray Companies	Boost Target	Overweight	$42.00 ➝ $50.00	Medium
6/18/2019	Wells Fargo & Company	Boost Target	Outperform	$42.00 ➝ $45.00	Medium
5/13/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$36.20	Low
5/13/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium
4/25/2019	BTIG Research	Reiterated Rating	Buy		High
2/13/2019	Argus	Boost Target	Buy	$43.00 ➝ $45.00	Medium
2/8/2019	SunTrust Banks	Reiterated Rating	Buy	$47.00	Low
2/8/2019	Guggenheim	Reiterated Rating	Buy	$48.00	Low
2/6/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Low
1/8/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$42.00	Low
11/27/2018	UBS Group	Initiated Coverage	Buy ➝ Buy	$45.00	High
11/21/2018	Oppenheimer	Reiterated Rating	Hold		Low
11/21/2018	BTIG Research	Reiterated Rating	Buy		Low
11/20/2018	SunTrust Banks	Boost Target	Buy	$44.00	Low
11/19/2018	Stephens	Reiterated Rating	In-Line ➝ Market Perform	$40.00	Medium
11/16/2018	Guggenheim	Boost Target	Buy	$45.00	Low
10/26/2018	Argus	Boost Target	Buy ➝ Buy	$41.00 ➝ $43.00	Low
10/25/2018	BTIG Research	Reiterated Rating	Buy	$45.00	Medium
10/24/2018	Oppenheimer	Set Target	Hold	$38.00	Medium
10/22/2018	Cowen	Set Target	Buy	$39.00 ➝ $42.00	Low
10/16/2018	BTIG Research	Reiterated Rating	Buy	$45.00	High
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$43.00	High
10/15/2018	Royal Bank of Canada	Boost Target	Top Pick	$42.00	High
10/2/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$38.00 ➝ $48.00	Low
9/25/2018	Oppenheimer	Reiterated Rating	Hold		Medium

(Data available from 9/23/2018 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

15 very positive mentions
16 positive mentions
6 negative mentions
0 very negative mentions

Mentions as of

2/25/2023

17 very positive mentions
32 positive mentions
7 negative mentions
6 very negative mentions

Mentions as of

3/27/2023

32 very positive mentions
37 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

4/26/2023

26 very positive mentions
49 positive mentions
10 negative mentions
0 very negative mentions

Mentions as of

5/26/2023

28 very positive mentions
41 positive mentions
10 negative mentions
2 very negative mentions

Mentions as of

6/25/2023

30 very positive mentions
45 positive mentions
9 negative mentions
11 very negative mentions

Mentions as of

7/25/2023

29 very positive mentions
104 positive mentions
27 negative mentions
15 very negative mentions

Mentions as of

8/24/2023

42 very positive mentions
108 positive mentions
14 negative mentions
20 very negative mentions

Mentions as of

9/23/2023

Current Sentiment

Recent Stories by Sentiment

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $53.60

$53.47

$54.11

50 Day Range

MA: $52.35

$50.19

$54.68

52 Week Range

Now: $53.60

$37.74

$55.38

Volume

9,439,902 shs

Average Volume

8,507,042 shs

Market Capitalization

$78.48 billion

P/E Ratio

89.33

Dividend Yield

N/A

Beta

0.78

Frequently Asked Questions

What sell-side analysts currently cover shares of Boston Scientific?: The following Wall Street analysts have issued reports on Boston Scientific in the last twelve months: 22nd Century Group, Inc., Argus, Barclays PLC, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., CL King, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, StockNews.com, TheStreet, Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for BSX.
What is the current price target for Boston Scientific?: 21 Wall Street analysts have set twelve-month price targets for Boston Scientific in the last year. Their average twelve-month price target is $60.10, suggesting a possible upside of 12.1%. UBS Group AG has the highest price target set, predicting BSX will reach $66.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $50.00 for Boston Scientific in the next year.
View the latest price targets for BSX.
What is the current consensus analyst rating for Boston Scientific?: Boston Scientific currently has 1 hold rating, 15 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BSX will outperform the market and that investors should add to their positions of Boston Scientific.
View the latest ratings for BSX.
What other companies compete with Boston Scientific?: Other companies that are similar to Boston Scientific include Becton, Dickinson and Company, Stryker, DexCom, ResMed and Baxter International. Learn More about companies similar to Boston Scientific.
How do I contact Boston Scientific's investor relations team?: Boston Scientific's physical mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider's listed phone number is (508) 683-4000 and its investor relations email address is bsxinvestorre[email protected]. The official website for Boston Scientific is www.bostonscientific.com. Learn More about contacing Boston Scientific investor relations.

Boston Scientific - BSX Stock Price Target and Predictions

Analyst Price Target for BSX

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.25 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Boston Scientific?

What is the current price target for Boston Scientific?

What is the current consensus analyst rating for Boston Scientific?

What other companies compete with Boston Scientific?

How do I contact Boston Scientific's investor relations team?